We are live on ! Find out more
NERM

New England Research & Management Portfolio holdings

AUM $257M
1-Year Est. Return 25.66%
This Fund
S&P 500
This Quarter Est. Return
+10.71%
1 Year Est. Return
+25.66%
3 Year Est. Return
+56.38%
5 Year Est. Return
+58.71%
10 Year Est. Return
+176.32%
AUM
$162M
AUM Growth
+$23.6M
Cap. Flow
+$10.6M
Cap. Flow %
6.58%
Top 10 Hldgs %
23.45%
Holding
171
New
38
Increased
27
Reduced
58
Closed
21

Top Buys

Rank Stock Value
1
APD icon
Air Products & Chemicals
APD
+$1.92M
2
LOW icon
Lowe's Companies
LOW
+$1.92M
3
MMM icon
3M
MMM
+$1.39M
4
CARR icon
Carrier Global
CARR
+$1.29M
5
KMX icon
CarMax
KMX
+$1.02M

Top Sells

Rank Stock Value
1
LDOS icon
Leidos
LDOS
+$1.17M
2
NVS icon
Novartis
NVS
+$1.09M
3
CHGG icon
Chegg
CHGG
+$1.07M
4
TER icon
Teradyne
TER
+$976K
5
LLY icon
Eli Lilly
LLY
+$929K

Sector Composition

Rank Sector Weight
1 Industrials 18.77%
2 Healthcare 18.64%
3 Technology 17.5%
4 Consumer Staples 14.2%
5 Consumer Discretionary 9.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INVH icon
51
Invitation Homes
INVH
$16.3B
$1.16M 0.72%
39,125
+18,525
+90% +$533K
SYY icon
52
Sysco
SYY
$38.1B
$1.11M 0.68%
14,904
+3,100
+26% +$213K
INDB icon
53
Independent Bank
INDB
$3.96B
$1.07M 0.66%
14,721
-313
-2% -$20.3K
AZN icon
54
AstraZeneca
AZN
$251B
$1.07M 0.66%
10,738
+7,863
+273% +$833K
PEP icon
55
PepsiCo
PEP
$185B
$1.07M 0.66%
7,188
+1,250
+21% +$178K
KMX icon
56
CarMax
KMX
$8.49B
$1.02M 0.63%
+10,850
New +$1.02M
DHI icon
57
D.R. Horton
DHI
$39.2B
$1M 0.62%
14,563
+11,550
+383% +$842K
K
58
DELISTED
Kellanova
K
$992K 0.61%
16,971
-1,931
-10% -$116K
LLY icon
59
Eli Lilly
LLY
$1.01T
$956K 0.59%
5,665
-6,225
-52% -$929K
MDT icon
60
Medtronic
MDT
$120B
$948K 0.59%
8,094
-450
-5% -$49.5K
INTC icon
61
Intel
INTC
$513B
$943K 0.58%
18,936
-6,477
-25% -$316K
AGR
62
DELISTED
Avangrid, Inc.
AGR
$909K 0.56%
19,993
+9,843
+97% +$484K
CWH icon
63
Camping World
CWH
$368M
$897K 0.55%
34,450
+23,200
+206% +$679K
SNA icon
64
Snap-on
SNA
$19.4B
$865K 0.54%
+5,055
New +$845K
FDX icon
65
FedEx
FDX
$73B
$850K 0.53%
3,275
ECL icon
66
Ecolab
ECL
$77B
$833K 0.52%
3,850
+100
+3% +$20.9K
PLD
67
DELISTED
PROLOGIS
PLD
$825K 0.51%
8,275
+700
+9% +$69.8K
XOM icon
68
ExxonMobil
XOM
$696B
$824K 0.51%
20,000
-1,338
-6% -$50.2K
AMZN icon
69
Amazon
AMZN
$2.68T
$814K 0.5%
5,000
+2,420
+94% +$386K
AZEK
70
DELISTED
The AZEK Co
AZEK
$798K 0.49%
+20,750
New +$749K
GNRC icon
71
Generac Holdings
GNRC
$10.3B
$773K 0.48%
+3,400
New +$732K
CL icon
72
Colgate-Palmolive
CL
$69.4B
$764K 0.47%
8,938
TER icon
73
Teradyne
TER
$52B
$762K 0.47%
6,354
-9,550
-60% -$976K
EL icon
74
Estee Lauder
EL
$34.8B
$734K 0.45%
2,758
HD icon
75
Home Depot
HD
$305B
$725K 0.45%
2,731

Similar funds

New England Research & Management's Q4 2020 Portfolio in Review

As of Q4 2020, New England Research & Management held 171 positions worth $162M, up 17% from $138M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

New England Research & Management deployed $10.6M of net new capital in Q4 2020, opening 38 new positions and adding to 27 existing holdings. Its largest new stake was Air Products & Chemicals: 6,825 shares worth $1.86M.

By sector, the portfolio is most concentrated in Industrials at 19% of assets, up from 15% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Teradyne, an estimated $976K trimmed.

  • New England Research & Management's largest Q4 2020 buy was Air Products & Chemicals: 6,825 shares worth $1.86M.
  • New England Research & Management added most to 3M in Q4 2020, an estimated $1.39M increase.
  • New England Research & Management's biggest Q4 2020 reduction was Teradyne, cutting an estimated $976K.
  • New England Research & Management fully exited Leidos in Q4 2020, selling an estimated $1.17M.
  • New England Research & Management's ten largest holdings make up 23% of its $162M portfolio in Q4 2020.
  • New England Research & Management opened 38 new positions and closed 21 in Q4 2020.
  • New England Research & Management's portfolio value rose 17% quarter-over-quarter to $162M.

Based on New England Research & Management's 13F filing for Q4 2020, filed 7 Jan 2021.